NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $221,247 | -2.5% | 3,985 | -23.1% | 0.08% | -1.2% |
| Q3 2022 | $227,000 | -80.3% | 5,185 | -84.1% | 0.08% | -78.1% |
| Q2 2022 | $1,155,000 | -9.6% | 32,600 | +3.9% | 0.38% | +14.7% |
| Q1 2022 | $1,277,000 | -63.1% | 31,390 | -15.4% | 0.33% | -58.1% |
| Q4 2021 | $3,464,000 | -39.8% | 37,095 | -28.2% | 0.78% | -40.8% |
| Q3 2021 | $5,755,000 | +27.3% | 51,640 | +29.7% | 1.32% | +29.5% |
| Q2 2021 | $4,520,000 | – | 39,815 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |